Decisions by regulatory agencies: are they evidence-based?

by Furberg Curt D
Published 2007-04-01

The usefulness of information on HDL-cholesterol: potential pitfalls of conventional assumptions

by Furberg Curt D
Published 2001-05-01

A new era in hypertension research: discussing the findings of ALLHAT

by Furberg Curt D
Published 2001-11-01

Withdrawal of cerivastatin from the world market

by Pitt Bertram, Furberg Curt D
Published 2001-09-01

Balancing commercial and public interests

by Sevick Mary, Hall Mark A, Furberg Curt D
Published 2004-07-01

Lead editorial: Trials – using the opportunities of electronic publishing to improve the reporting of randomised trials

by Grimshaw Jeremy M, Furberg Curt D, Altman Douglas G, Rothwell Peter M
Published 2006-03-01

Five years of <it>Trials</it>

by Altman Douglas G, Hrynaszkiewicz Iain, Furberg Curt D, Grimshaw Jeremy M, Rothwell Peter M
Published 2011-11-01

A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization

by Gunaratne Padma S, Somasundaram Noel P, Dissanayake Wasantha P, Mendis Shanthi, Soliman Elsayed Z, Jayasingne I Kumudini, Furberg Curt D
Published 2011-01-01

Experience collecting interim data on mortality: an example from the RALES study

by Kulbertus Henri, Furberg Curt D, Boissel Jean-Pierre, Julian Desmond, Asner Debra, Palensky Jolie, Wittes Janet, Pocock Stuart, Roniker Barbara
Published 2001-02-01